Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard C Becker

Showing results (221-230 of 436) with videos related to

Pageof 44
Sort By:
American Heart Journal|June 1, 2002
Influence of patient characteristics and renal function on factor Xa inhibition pharmacokinetics and pharmacodynamics after enoxaparin administration in non-ST-segment elevation acute coronary syndromesRichard C Becker, Frederick A Spencer, Michael Gibson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 17, 2011
Rapidly regulating platelet activity in vivo with an antidote controlled platelet inhibitorShahid M Nimjee, Jens D Lohrmann, Haichen Wang, et al.
Iscience|January 3, 2023
Genetic ablation of diabetes-associated gene <i>Ccdc92</i> reduces obesity and insulin resistance in miceLu Ren, Wa Du, Dan Song, et al.
Stroke|April 11, 2013
Ticagrelor in patients with acute coronary syndromes and stroke: interpretation of subgroups in clinical trialsStefan K James, Karen S Pieper, Christopher P Cannon, et al.
Thrombosis and Haemostasis|September 1, 2010
Effect of apixaban, an oral and direct factor Xa inhibitor, on coagulation activity biomarkers following acute coronary syndromeRichard C Becker, John H Alexander, L Kristin Newby, et al.
Stroke|June 27, 2013
Response to letter regarding article, "Ticagrelor in patients with acute coronary syndromes and stroke: interpretation of subgroups in clinical trials"Stefan K James, Robert F Storey, Karen S Pieper, et al.
Platelets|June 1, 2018
Equilibrative nucleoside transporter 1 gene polymorphisms and clinical outcomes following acute coronary syndromes: findings from the PLATelet inhibition and patient Outcomes (PLATO) studyWilliam A E Parker, Niclas Eriksson, Richard C Becker, et al.
Circulation. Cardiovascular Interventions|October 20, 2011
Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: a North American perspective: executive summaryDavid P Faxon, John W Eikelboom, Peter B Berger, et al.
Circulation. Cardiovascular Interventions|December 22, 2011
Platelet-mediated thrombosis and drug-eluting stentsJuan F Granada, Matthew J Price, Patricia A French, et al.
Journal of Medical Systems|May 28, 2010
Economic assessment of thrombocytopenia: CATCH RegistryEric L Eisenstein, Emily F Honeycutt, Kevin J Anstrom, et al.
Pageof 44

Showing results (221-230 of 436) with videos related to

Sort By:
Pageof 44
American Heart Journal|June 1, 2002
Influence of patient characteristics and renal function on factor Xa inhibition pharmacokinetics and pharmacodynamics after enoxaparin administration in non-ST-segment elevation acute coronary syndromesRichard C Becker, Frederick A Spencer, Michael Gibson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 17, 2011
Rapidly regulating platelet activity in vivo with an antidote controlled platelet inhibitorShahid M Nimjee, Jens D Lohrmann, Haichen Wang, et al.
Iscience|January 3, 2023
Genetic ablation of diabetes-associated gene <i>Ccdc92</i> reduces obesity and insulin resistance in miceLu Ren, Wa Du, Dan Song, et al.
Stroke|April 11, 2013
Ticagrelor in patients with acute coronary syndromes and stroke: interpretation of subgroups in clinical trialsStefan K James, Karen S Pieper, Christopher P Cannon, et al.
Thrombosis and Haemostasis|September 1, 2010
Effect of apixaban, an oral and direct factor Xa inhibitor, on coagulation activity biomarkers following acute coronary syndromeRichard C Becker, John H Alexander, L Kristin Newby, et al.
Stroke|June 27, 2013
Response to letter regarding article, "Ticagrelor in patients with acute coronary syndromes and stroke: interpretation of subgroups in clinical trials"Stefan K James, Robert F Storey, Karen S Pieper, et al.
Platelets|June 1, 2018
Equilibrative nucleoside transporter 1 gene polymorphisms and clinical outcomes following acute coronary syndromes: findings from the PLATelet inhibition and patient Outcomes (PLATO) studyWilliam A E Parker, Niclas Eriksson, Richard C Becker, et al.
Circulation. Cardiovascular Interventions|October 20, 2011
Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: a North American perspective: executive summaryDavid P Faxon, John W Eikelboom, Peter B Berger, et al.
Circulation. Cardiovascular Interventions|December 22, 2011
Platelet-mediated thrombosis and drug-eluting stentsJuan F Granada, Matthew J Price, Patricia A French, et al.
Journal of Medical Systems|May 28, 2010
Economic assessment of thrombocytopenia: CATCH RegistryEric L Eisenstein, Emily F Honeycutt, Kevin J Anstrom, et al.
Pageof 44